Join
Live feed
·
INSIDERFilingvia Quantisnow
Jupiter Neurosciences Inc. logo

CEO and Chairman Rosen Christer converted options into 973,466 shares and bought $7,986 worth of shares (7,816 units at $1.02), increasing direct ownership by 10% to 11,075,292 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
JUNS· Jupiter Neurosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JUNS (Jupiter Neurosciences Inc.) and more on Quantisnow.